Immunocytochemical analysis of prostate stem cell antigen as an adjunct marker for the detection of urothelial transitional cell carcinoma in voided urine specimens

Journal of Urology

Volumn 169, Issue 6, 2003, Pages 2094-2100

  Cheng, Lirong ^b   Reiter, Robert E ^a   Jin, Yusheng ^b   Sharon, Hirschowitz ^b   Wieder, Jeffrey ^b   Lane, Timothy F ^b   Rao, Jianyu ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Antigens, surface; Carcinoma, urothelium; Cytology, urine

Indexed keywords

MEMBRANE ANTIGEN; PROSTATE STEM CELL ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CYTOMETRY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PAPANICOLAOU TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

EID: 0037612079     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000064929.43602.17     Document Type: Article

References (19)

1. Demay, R. M.: Exfoliative cytology. In: The Art and Science of Cytopathology. Chicago: ASCP Press, vol. 1, chapt. 10, pp. 386-420, 1996
2. Kern, W. H.: The cytology of transitional cell carcinoma of the urinary bladder. Acta Cytol, 19: 420, 1975
3. Renshaw, A. A., Nappi, D. and Weinberg, D. S.: Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural, and morphometric criteria in cystoscopically obtained urine. Acta Cytol, 40: 676, 1996
4. Koss, L. G., Deitch, D., Ramanathan, R. and Sherman, A. B.: Diagnostic value of cytology of voided urine. Acta Cytol, 29: 810, 1985
5. Murphy, W. M., Soloway, M. S., Jukkola, A. F., Crabtree, M. N. and Ford, K. S.: Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer, 53: 1555, 1984
6. Hemstreet, G. P., III, Bonner, R. B., Hurst, R. E. and Rao, J. Y.: Cytology of bladder cancer. In: Comprehensive Textbook of Genitourinary Oncology, 2nd ed. Edited by N. J. Vogelzang, W. U. Shipley, P. T. Scardino, D. S. Coffey and B. J. Miles. Baltimore: Lippincott Williams & Wilkins, chapt. 21, pp. 322-332, 1999
7. Rao, J. Y., Hurst, R. E. and Hemstreet, G. P.: Molecular pathology of early bladder cancer. In: Molecular Pathology of Early Cancer. Edited by A. Gazdar, S. Srivastava and D. E. Henson. Amsterdam: IOS Press, chapt. 5, 1999
8. Han, K. R., Pantuck, A. J., Belldegrun, A. S. and Rao, J. Y.: Tumor markers for the early detection of bladder cancer. Front Biosci, 7: e19, 2002
9. Amara, N., Palapattu, G. S., Schrage, M., Gu, Z., Thomas, G. V., Dorey, F. et al: Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res, 61: 4660, 2001
10. Watabe, T., Lin, M., Ide, H., Donjacour, A. A., Cunha, G. R., Witte, 0. N. et al: Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter. Proc Natl Acad Sci USA, 99: 401, 2002
11. Dubey, P., Wu, H., Reiter, R. E. and Witte, 0. N.: Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression. Cancer Res, 61: 3256, 2001
12. Bahrenberg, G., Brauers, A., Joost, H. G. and Jakse, G.: Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Com, 275: 783, 2000
13. Reiter, R. E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M. et al: Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA, 95: 1735, 1998
14. Ross, S., Spencer, S. D., Lasky, L. A. and Koeppen, H.: Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis. Am J Pathol, 158: 809, 2001
15. Saffran, D. C., Raitano, A. B., Hubert, R. S., Witte, O. N., Reiter, R. E. and Jakobovits, A.: Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc Natl Acad Sci USA, 98: 2658, 2001
16. Gu, Z., Thomas, G., Yamashiro, J., Shintaku, I. P., Dorey, F., Raitano, A. et al: Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene, 19: 1288, 2000
17. Reiter, R. E., Sato, I., Thomas, G., Qian, J., Gu, Z., Watabe, T. et al: Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer. Genes Chromosomes Cancer, 27: 95, 2000
18. Dannull, J., Diener, P. A., Prikler, L., Furstenberger, G., Cerny, T., Schmid, U. et al: Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer Res, 60: 5522, 2000
19. Ross, S., Spencer, S. D., Holcomb, I., Tan, C., Hongo, J., Devaux, B. et al: Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res, 62: 2546, 2002